Related Experiment Video

Updated: Aug 16, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Stroke in two children with Mycoplasma pneumoniae infection. A causal or casual relationship?

Salvatore Leonardi1, Piero Pavone, Novella Rotolo

  • 1Paediatric Department, University of Catania, Catania, Italy. leonardi@unict.it

The Pediatric Infectious Disease Journal
|September 9, 2005
PubMed

Insights

Mycoplasma pneumoniae infection can cause stroke in children through direct invasion or immune responses. While antibiotics are ineffective, prompt immunosuppressive therapy may aid recovery.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pediatrics

Background:

  • Mycoplasma pneumoniae is a common respiratory pathogen.
  • Cerebrovascular events are rare complications of Mycoplasma pneumoniae infections, particularly in children.
  • Understanding the pathogenesis is crucial for effective management.

Observation:

  • Two pediatric cases of stroke associated with Mycoplasma pneumoniae infection are presented.
  • Clinical presentation and neurological deficits were observed in affected children.

Findings:

  • Two distinct pathogenic pathways were identified: direct invasion of the central nervous system by Mycoplasma pneumoniae and immune-mediated mechanisms.
  • Macrolide antibiotic therapy, initiated promptly, did not prevent stroke development.
  • Immediate and aggressive immunosuppressive treatment appeared to correlate with improved patient recovery.

Implications:

  • This study highlights the potential neurological complications of Mycoplasma pneumoniae infections in children.
  • It suggests that immunosuppressive therapy, rather than solely antibiotics, may be a critical component in managing stroke secondary to Mycoplasma pneumoniae.
  • Further research is warranted to elucidate the precise mechanisms and optimize treatment strategies for these rare but severe cases.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...